Prospective and Comparative Analysis of Arthroscopic and Open Surgery for Hallux Rigidus - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

January 30, 2006

Last Updated Date

February 12, 2009

Start Date ^†

Current Primary Outcome Measures ^†

Duration of hospitalisation
Duration of rehabilitation and sick leave
Wound healing

Original Primary Outcome Measures ^†

Duration of hospitalisation
Duration of revalidation and absence at work
Wound heeling

Change History

Complete list of historical versions of study NCT00284362 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

Prospective and Comparative Analysis of Arthroscopic and Open Surgery for Hallux Rigidus

Official Title ^†

Prospective and Comparative Analysis of Arthroscopic and Open Surgery for Hallux Rigidus

Brief Summary

Comparison between arthroscopic and open surgery for hallux rigidus.

Detailed Description

Study Phase

Study Type ^†

Interventional

Study Design ^†

Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study

Condition ^†

Hallux Rigidus

Intervention ^†

Procedure: Arthroscopic or open surgery for hallux rigidus

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Recruiting

Enrollment ^†

Completion Date

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria: - Hallux rigidus Exclusion Criteria: -

Gender

Both

Ages

40 Years to 60 Years

Accepts Healthy Volunteers

Contacts ^††

Contact: Edwin van Ovost, MD

+ 32 9 332 22 48

edwin.vanovost@UGent.be

Location Countries ^†

Belgium

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00284362

Responsible Party

René Verdonk, University Hospital Ghent

Secondary IDs ^††

Study Sponsor ^†

University Hospital, Ghent

Collaborators ^††

Investigators ^†

Principal Investigator:

Rene Verdonk, MD, PhD

University Hospital, Ghent

Information Provided By

University Hospital, Ghent

Verification Date

February 2009

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.